Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fangfeng Tongsheng Pill is a traditional Chinese medicine (TCM) formulation developed and marketed by Shandong Wohua Pharmaceutical Co., Ltd. It is a complex herbal preparation based on a classic TCM formula intended to treat 'colds on the surface and heat inside,' a pattern often referred to as wind-heat toxin. The formulation typically incorporates multiple herbal ingredients, including Saposhnikovia root (Fangfeng), Schizonepeta, Chinese mint, Chinese rhubarb, and gardenia fruit. It is administered orally and is indicated for the relief of symptoms such as constipation and various skin disorders associated with wind-heat patterns. As a traditional herbal product, it functions through the synergistic effects of its multiple components rather than a single defined molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fangfeng Tongsheng Pill.